Literature DB >> 1632461

Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans.

A C van der Wal1, P K Das, A J Tigges, A E Becker.   

Abstract

The differentiation of macrophages present in diffuse intimal thickening, fatty streaks, and atheromatous plaques, was analyzed with immunohistochemical methods, using segments of aorta, coronary, and carotid arteries obtained at autopsy. Various differentiation antigens were studied with the monoclonal antibodies anti-HLA-DR, EBM-11, Leu M3, OKM1, and OKM5. Adjacent sections were stained for lipids (oil red O) and lysosomal activity (acid phosphatase). Almost all macrophages identified with the pan-macrophage antibody EBM-11, also stained with the anti-HLA-DR antibody. Diffuse intimal thickening showed a predominance of Leu M3+ cells; fatty streaks also showed OKM1+ and OKM5+ macrophages. Classical atheromatous plaques showed a gradual shift in phenotypic expression towards the center of the lesion. Cells in the superficial layers were positive only with Leu M3, deeper localized cells showed double expression of Leu M3 and OKM1 or double expression of OKM1 and OKM5. Cells that were localized adjacent to the atheromatous debris stained only with OKM5. The phenotypic changes occurred in parallel with an increase in both fat uptake and lysosomal activity of the macrophages. This shift in phenotypic expression suggests a process of differentiation and maturation of the macrophages involved. The results indicate that macrophages within the arterial intima are activated and mature towards cells that express receptors for adhesion proteins and complement during the development of atherosclerotic plaques. This may imply that the macrophages involved in lipid metabolism also have a potential to act as effector cells in a chronic inflammatory process, and thus, may contribute to the progression of an atherosclerotic plaque. Functional studies of macrophage subpopulations are needed to verify this hypothesis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1632461      PMCID: PMC1886580     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  30 in total

Review 1.  The pathogenesis of atherosclerosis--an update.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1986-02-20       Impact factor: 91.245

Review 2.  The mononuclear phagocytic system: a review.

Authors:  A Lasser
Journal:  Hum Pathol       Date:  1983-02       Impact factor: 3.466

3.  Monoclonal anti-human monocyte antibodies OKM1 and OKM5 possess distinctive tissue distributions including differential reactivity with vascular endothelium.

Authors:  D M Knowles; B Tolidjian; C Marboe; V D'Agati; M Grimes; L Chess
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

4.  Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression.

Authors:  E L Reinherz; P C Kung; J M Pesando; J Ritz; G Goldstein; S F Schlossman
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

Review 5.  The pathogenesis of atherosclerosis: atherogenesis and inflammation.

Authors:  J M Munro; R S Cotran
Journal:  Lab Invest       Date:  1988-03       Impact factor: 5.662

6.  Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque.

Authors:  L Jonasson; J Holm; O Skalli; G Bondjers; G K Hansson
Journal:  Arteriosclerosis       Date:  1986 Mar-Apr

7.  Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies.

Authors:  A Dimitriu-Bona; G R Burmester; S J Waters; R J Winchester
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

8.  Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions.

Authors:  A M Gown; T Tsukada; R Ross
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

9.  T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis.

Authors:  E E Emeson; A L Robertson
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

10.  A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule.

Authors:  F Sanchez-Madrid; J A Nagy; E Robbins; P Simon; T A Springer
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more
  11 in total

1.  Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta.

Authors:  S P Evanko; E W Raines; R Ross; L I Gold; T N Wight
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

2.  Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes.

Authors:  S Sugiyama; Y Okada; G K Sukhova; R Virmani; J W Heinecke; P Libby
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

3.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

Authors:  M Febbraio; E A Podrez; J D Smith; D P Hajjar; S L Hazen; H F Hoff; K Sharma; R L Silverstein
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

Review 4.  Participation of innate and acquired immunity in atherosclerosis.

Authors:  L K Curtiss; N Kubo; N K Schiller; W A Boisvert
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

5.  Colony-stimulating factor-1 signaling suppresses renal crystal formation.

Authors:  Kazumi Taguchi; Atsushi Okada; Hiroshi Kitamura; Takahiro Yasui; Taku Naiki; Shuzo Hamamoto; Ryosuke Ando; Kentaro Mizuno; Noriyasu Kawai; Keiichi Tozawa; Kenichi Asano; Masato Tanaka; Ichiro Miyoshi; Kenjiro Kohri
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

6.  Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification.

Authors:  S Hirota; M Imakita; K Kohri; A Ito; E Morii; S Adachi; H M Kim; Y Kitamura; C Yutani; S Nomura
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

7.  Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions.

Authors:  M D Rekhter; K Zhang; A S Narayanan; S Phan; M A Schork; D Gordon
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

8.  Soluble FcgammaRIIIa(Mphi) levels in plasma correlate with carotid maximum intima-media thickness (IMT) in subjects undergoing an annual medical checkup.

Authors:  Midori Masuda; Katsuya Amano; Shi Yan Hong; Noriko Nishimura; Masayoshi Fukui; Masamichi Yoshika; Yutaka Komiyama; Hiroya Masaki; Toshiji Iwasaka; Hakuo Takahashi
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

Review 9.  Molecular pathways regulating macrophage polarization: implications for atherosclerosis.

Authors:  Marten A Hoeksema; J Lauran Stöger; Menno P J de Winther
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

10.  Transmembrane protein 106a activates mouse peritoneal macrophages via the MAPK and NF-κB signaling pathways.

Authors:  Hui Dai; Dong Xu; Jing Su; Jingyuan Jang; Yingyu Chen
Journal:  Sci Rep       Date:  2015-07-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.